In 2026, the Global Artesunate Tablet Market is a pillar of the international effort to eradicate malaria. As the World Health Organization (WHO) and various governments push for Artemisinin-based Combination Therapies (ACTs) as the first-line treatment for uncomplicated malaria, the market is shifting toward fixed-dose combinations to prevent drug resistance and simplify patient adherence.
Market Valuation & Forecast (2025–2036)
The Global Artesunate Tablet Market was valued at approximately USD 125 Million in 2025. It is projected to reach USD 228 Million by 2036, growing at a CAGR of 5.6% during the forecast period. While injectable artesunate dominates the severe malaria segment, tablets remain the highest-volume format for mass distribution in rural and community-based health programs.
Segments Analysis
The market is categorized by formulation complexity and patient-specific dosing needs.
| Category | Key Segments |
| By Type | Mono-Artesunate (Still used in specific protocols), Compound/ACT Artesunate (Artesunate + Amodiaquine, Artesunate + Mefloquine, etc.). |
| By Dosage | 50 mg (Pediatric), 100 mg (Standard Adult), 200 mg. |
| By Application | Uncomplicated Malaria (Primary Use), Severe Malaria Post-Treatment (Oral step-down therapy), Experimental (Oncology/Autoimmune research). |
| By End-User | Public Sector (Government Procurement/NGOs), Private Sector (Hospitals, Clinics, Retail Pharmacies). |
Regional Analysis
-
Middle East & Africa: The largest market by volume. Sub-Saharan Africa remains the epicenter of demand, heavily supported by the Global Fund and USAID’s President’s Malaria Initiative.
-
Asia-Pacific: The fastest-growing region. India, Vietnam, and Thailand are both major consumers and primary manufacturing hubs, with a strong focus on high-quality generic production.
-
North America & Europe: Niche markets focused on travel medicine and stockpiling for military/international aid organizations.
-
Latin America: Moderate growth driven by localized outbreaks in the Amazon basin.
Key Players
-
Global Leaders: Fosun Pharma (Guilin Pharmaceutical), Sanofi, Novartis AG, Ipca Laboratories.
-
Generic & Regional Powerhouses: Cipla Ltd., Ajanta Pharma, Shin Poong Pharmaceutical, Macleods Pharmaceuticals.
-
Niche Specialists: Acino, AdvaCare Pharma, Wellona Pharma, Torso Healthcare.
Porter’s Five Forces
-
Bargaining Power of Buyers (Very High): The market is dominated by institutional buyers (UNICEF, WHO). Procurement agencies dictate pricing and quality standards (WHO Prequalification).
-
Threat of New Entrants (Low): Stringent regulatory hurdles and the requirement for WHO Prequalification prevent small-scale generic manufacturers from entering the global tender market.
-
Bargaining Power of Suppliers (Moderate): Suppliers of Artemisia annua (raw plant material) can influence prices based on crop yields, but synthetic artemisinin technology is starting to stabilize this.
-
Threat of Substitutes (Moderate): Next-generation non-artemisinin compounds are in clinical trials to combat rising resistance, but artesunate remains the gold standard for now.
-
Competitive Rivalry (High): Intense competition among Indian and Chinese manufacturers for high-volume government tenders.
SWOT Analysis
-
Strengths: Rapid parasite clearance; well-established safety profile; high efficacy in children and pregnant women.
-
Weaknesses: Risk of monotherapy resistance; reliance on seasonal plant harvests for raw materials.
-
Opportunities: Expansion of e-pharmacy distribution in Africa; potential for Artesunate as an adjunct therapy in cancer treatment.
-
Threats: Counterfeit drugs in unregulated markets; emerging "PfKelch13" gene mutations indicating artemisinin resistance in Southeast Asia.
Trend Analysis 2026
-
Digital Supply Chain Tracking: Implementation of blockchain and mobile apps to track artesunate shipments from factory to remote clinics, reducing the prevalence of counterfeit tablets.
-
Pediatric Optimization: Development of "dispersible" tablets that dissolve in water, specifically designed to improve dosing accuracy for infants.
-
Shift to Fixed-Dose Combinations (FDCs): Phasing out "loose" tablet co-blisters in favor of single tablets containing both artesunate and its partner drug to ensure compliance.
Drivers & Challenges
-
Driver: Massive funding from international organizations aiming for a "Malaria-Free World" by 2030.
-
Driver: Increased diagnostic testing (RDTs) ensuring that artesunate is prescribed only when necessary, improving market efficiency.
-
Challenge: The high cost of maintaining "Cold Chain" logistics in tropical regions for temperature-sensitive blister packs.
-
Challenge: Political instability in endemic regions disrupting essential medicine delivery.
Value Chain Analysis
-
Artemisia annua Cultivation: Primarily in China, Vietnam, and East Africa.
-
Extraction & Semi-Synthesis: Converting raw plant extract into Artesunate API.
-
Formulation: Tablet manufacturing in WHO-GMP certified facilities.
-
Procurement: Large-scale tenders by global health bodies.
-
Distribution: "Last-mile" delivery to rural health posts and hospital pharmacies.
Quick Recommendations for Stakeholders
-
For Manufacturers: Secure WHO Prequalification (PQ) status; it is the absolute "key to the door" for 80% of the global market volume.
-
For NGOs/Procurement: Invest in Point-of-Care Testing (POCT) alongside drug delivery to prevent over-prescription and preserve drug efficacy.
-
For Investors: Look toward companies developing synthetic artemisinin, as they will hold the competitive edge in pricing and supply chain stability.
1. Market Overview of Artesunate Tablet
1.1 Artesunate Tablet Market Overview
1.1.1 Artesunate Tablet Product Scope
1.1.2 Market Status and Outlook
1.2 Artesunate Tablet Market Size by Regions:
1.3 Artesunate Tablet Historic Market Size by Regions
1.4 Artesunate Tablet Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Artesunate Tablet Sales Market by Type
2.1 Global Artesunate Tablet Historic Market Size by Type
2.2 Global Artesunate Tablet Forecasted Market Size by Type
2.3 Monoaromatic Artesunate
2.4 Compound Artesunate
3. Covid-19 Impact Artesunate Tablet Sales Market by Application
3.1 Global Artesunate Tablet Historic Market Size by Application
3.2 Global Artesunate Tablet Forecasted Market Size by Application
3.3 Hospital
3.4 Clinic
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Artesunate Tablet Production Capacity Market Share by Manufacturers
4.2 Global Artesunate Tablet Revenue Market Share by Manufacturers
4.3 Global Artesunate Tablet Average Price by Manufacturers
5. Company Profiles and Key Figures in Artesunate Tablet Business
5.1
5.1.1 Company Profile
5.1.2 Artesunate Tablet Product Specification
5.1.3 Artesunate Tablet Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Artesunate Tablet Market Size
6.2 North America Artesunate Tablet Key Players in North America
6.3 North America Artesunate Tablet Market Size by Type
6.4 North America Artesunate Tablet Market Size by Application
7. East Asia
7.1 East Asia Artesunate Tablet Market Size
7.2 East Asia Artesunate Tablet Key Players in North America
7.3 East Asia Artesunate Tablet Market Size by Type
7.4 East Asia Artesunate Tablet Market Size by Application
8. Europe
8.1 Europe Artesunate Tablet Market Size
8.2 Europe Artesunate Tablet Key Players in North America
8.3 Europe Artesunate Tablet Market Size by Type
8.4 Europe Artesunate Tablet Market Size by Application
9. South Asia
9.1 South Asia Artesunate Tablet Market Size
9.2 South Asia Artesunate Tablet Key Players in North America
9.3 South Asia Artesunate Tablet Market Size by Type
9.4 South Asia Artesunate Tablet Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Artesunate Tablet Market Size
10.2 Southeast Asia Artesunate Tablet Key Players in North America
10.3 Southeast Asia Artesunate Tablet Market Size by Type
10.4 Southeast Asia Artesunate Tablet Market Size by Application
11. Middle East
11.1 Middle East Artesunate Tablet Market Size
11.2 Middle East Artesunate Tablet Key Players in North America
11.3 Middle East Artesunate Tablet Market Size by Type
11.4 Middle East Artesunate Tablet Market Size by Application
12. Africa
12.1 Africa Artesunate Tablet Market Size
12.2 Africa Artesunate Tablet Key Players in North America
12.3 Africa Artesunate Tablet Market Size by Type
12.4 Africa Artesunate Tablet Market Size by Application
13. Oceania
13.1 Oceania Artesunate Tablet Market Size
13.2 Oceania Artesunate Tablet Key Players in North America
13.3 Oceania Artesunate Tablet Market Size by Type
13.4 Oceania Artesunate Tablet Market Size by Application
14. South America
14.1 South America Artesunate Tablet Market Size
14.2 South America Artesunate Tablet Key Players in North America
14.3 South America Artesunate Tablet Market Size by Type
14.4 South America Artesunate Tablet Market Size by Application
15. Rest of the World
15.1 Rest of the World Artesunate Tablet Market Size
15.2 Rest of the World Artesunate Tablet Key Players in North America
15.3 Rest of the World Artesunate Tablet Market Size by Type
15.4 Rest of the World Artesunate Tablet Market Size by Application
16 Artesunate Tablet Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Segments Analysis
The market is categorized by formulation complexity and patient-specific dosing needs.
| Category | Key Segments |
| By Type | Mono-Artesunate (Still used in specific protocols), Compound/ACT Artesunate (Artesunate + Amodiaquine, Artesunate + Mefloquine, etc.). |
| By Dosage | 50 mg (Pediatric), 100 mg (Standard Adult), 200 mg. |
| By Application | Uncomplicated Malaria (Primary Use), Severe Malaria Post-Treatment (Oral step-down therapy), Experimental (Oncology/Autoimmune research). |
| By End-User | Public Sector (Government Procurement/NGOs), Private Sector (Hospitals, Clinics, Retail Pharmacies). |
Regional Analysis
-
Middle East & Africa: The largest market by volume. Sub-Saharan Africa remains the epicenter of demand, heavily supported by the Global Fund and USAID’s President’s Malaria Initiative.
-
Asia-Pacific: The fastest-growing region. India, Vietnam, and Thailand are both major consumers and primary manufacturing hubs, with a strong focus on high-quality generic production.
-
North America & Europe: Niche markets focused on travel medicine and stockpiling for military/international aid organizations.
-
Latin America: Moderate growth driven by localized outbreaks in the Amazon basin.
Key Players
-
Global Leaders: Fosun Pharma (Guilin Pharmaceutical), Sanofi, Novartis AG, Ipca Laboratories.
-
Generic & Regional Powerhouses: Cipla Ltd., Ajanta Pharma, Shin Poong Pharmaceutical, Macleods Pharmaceuticals.
-
Niche Specialists: Acino, AdvaCare Pharma, Wellona Pharma, Torso Healthcare.
